Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Freeline Therapeutics Ltd.

freelinetx.com

Latest From Freeline Therapeutics Ltd.

Finance Watch: Forma Raises $100m In Quest To Become A Sickle Cell Leader

The firm reorganized to focus on hemoglobinopathies and cancers after Celgene ended a multi-drug partnership. Also, Flagship funds a gene therapy start-up and brings in a business development veteran, Ultragenyx raises $320m in a royalty deal and Paratek secures up to $285m from BARDA. 

Financing Business Strategies

Only One In Seven PRIME Applications Meets EMA Test

Of the 14 applications for entry onto the European Medicines Agency’s priority medicines scheme during the first two months of 2019, only two – from AstraZeneca and Freeline – made the grade.
Europe Market Access

Follow The Money, An Interactive Biotech Financing Map

In 2018, while biotech venture activity spoke mainly with an American accent, China emerged as the world’s third most active cluster, while the UK led the way in Europe.

Commercial Financing

CEO of New UK Cell And Gene Therapy Hub Says 'All Systems Are Go'

CEO of the Stevenage-based center hopes the new cell and gene manufacturing hub will see a growing life sciences ecosystem coalesce around it.

Regenerative Medicine United Kingdom
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Freeline Therapeutics Ltd.
  • Senior Management
  • Anne Prener, PhD, CEO
    Amit Nathwani, MD, PhD, CSO
    Jan Thirkettle, PhD, Chief Dev. Officer
    Natalia Misciatelli, PhD, SVP, Strategy & Bus. Oper.
    Jane Withrow, PhD, VP, Fin.
  • Contact Info
  • Freeline Therapeutics Ltd.
    Phone: 1438 906870
    Stevenage Bioscience Catalyst
    Gunnels Wood Rd
    Stevenage, SG1 2FX
    UK
UsernamePublicRestriction

Register